A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity.
Ichiyama K, Yokoyama-Kumakura S, Tanaka Y, Tanaka R, Hirose K, Bannai K, Edamatsu T, Yanaka M, Niitani Y, Miyano-Kurosaki N, Takaku H, Koyanagi Y, Yamamoto N.
Ichiyama K, et al. Among authors: tanaka r, tanaka y.
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4185-90. doi: 10.1073/pnas.0630420100. Epub 2003 Mar 17.
Proc Natl Acad Sci U S A. 2003.
PMID: 12642669
Free PMC article.